Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Toxic Substances and Health
 
Section Contents
 
Storage
Metabolism
Bioaccumulation
 
Case Contents
 
Cover Page
Goals and Objectives
Case Study, Pretest
Exposure Pathways
Who is at Risk
Physiologic Effects
Clinical Evaluation
Laboratory Tests
Treatment
Standards, Regulations
Suggested Reading
Answers
Sources of Information
 
Case Studies (CSEM)
 
CSEM Home
Continuing Education
Online Registration
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Polychlorinated Biphenyls (PCB) Toxicity
Biological Fate


PCBs are stored in adipose tissues.

Although PCBs are readily absorbed into the body, they are only slowly metabolized and excreted. Animal studies suggest that absorbed PCBs partition between the aqueous and lipid compartments of the body in a biphasic pattern. After first distributing preferentially to the liver and muscle tissue, PCBs are subsequently redistributed to the adipose tissue, skin, and other fat-containing organs.


The liver is the primary site of PCB metabolism.

The liver is the primary site of PCB metabolism, which occurs via hydroxylation and conjugation with glucuronic acid and sulfates. Glucuronide and sulfate conjugates are excreted mainly in the urine, whereas hydroxylated metabolites are excreted mainly in the bile.

The rate of individual congener metabolism depends on the number and position of chlorine atoms. In rats, the half-lives of PCB congeners range from 1 to 460 days, depending on the degree of chlorination. In general, less-chlorinated isomers are more readily metabolized than are more highly chlorinated congeners. As a result of this preferential metabolism, more highly chlorinated congeners tend to remain in the body longer than do less-chlorinated congeners. Highly chlorinated congeners therefore tend to become more concentrated in adipose tissues, where they are stored in solubilized form.


The slow metabolism of PCBs leads to bioaccumulation.

Excretion of PCBs is very slow, so bioaccumulation occurs even at low exposure levels. As long as exposure continues, a true steady state is never achieved. Background levels of PCBs in human sera are typically <20 ppb and residues measured in human milk have values ranging from 40 to 100 ppb. Reported levels in adipose tissue range from 1 to 2 ppm.


Challenge Questions

3. Explain why patients with Gilbert syndrome might be at increased risk for adverse effects due to PCB exposure.

Previous Section

Next Section

Revised 2000-09-30.